Your shopping cart is currently empty

VEGFR-2-IN-72 is a selective inhibitor of VEGFR-2 with an IC50 of 22.2 nM. It exhibits anticancer activity against human liver cancer cell lines HepG2 and Hep3B, with IC50 values of 15.7 μM and 2.4 μM, respectively. VEGFR-2-IN-72 can cause mild cell cycle arrest and induces apoptosis (aopoptosis). It is suitable for research in hepatocellular carcinoma (HCC).
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | VEGFR-2-IN-72 is a selective inhibitor of VEGFR-2 with an IC50 of 22.2 nM. It exhibits anticancer activity against human liver cancer cell lines HepG2 and Hep3B, with IC50 values of 15.7 μM and 2.4 μM, respectively. VEGFR-2-IN-72 can cause mild cell cycle arrest and induces apoptosis (aopoptosis). It is suitable for research in hepatocellular carcinoma (HCC). |
| Targets&IC50 | VEGFR2:22.2 nM |
| In vitro | VEGFR-2-IN-72 (Compound 3i), when applied at concentrations of 0.5-5 μM for 24 hours, inhibits colony formation and induces apoptosis in Hep3B cells via the mitochondrial pathway, while also causing a slight delay in the S phase of these cells. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.